7 ML cemiplimab-rwlc 50 MG/ML Injection [Libtayo]
RxNorm concept 2058835, branded drug (sbd). Prescribable name: LIBTAYO 350 MG in 7 ML Injection.
- RxCUI
- 2058835
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2058835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Libtayo 350 MG per 7 ML Injection; Libtayo 50 MG/ML per 7 ML Injection
Related concepts
- cemiplimab-rwlc 50 MG/ML (SCDC, consists of)
- cemiplimab-rwlc 50 MG/ML [Libtayo] (SBDC, consists of)
- Injection (DF, has dose form)
- Libtayo (BN, has ingredient)
- 7 ML cemiplimab-rwlc 50 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2058835 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2058835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2058835. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.